Free shipping

Lactin-V for Recurrent UTIs: The 2011 Trial

A trial left prevention uncertain.

Woman preparing consultation notes.
In this article
  1. The comparison
  2. Interpretation
  3. Availability
  4. Getting assessed

The comparison

After antibiotics, 100 premenopausal women were randomized 50/50 to vaginal CTV-05 or placebo. The paper required age 18–40 and a prior treated UTI within the previous 12 months; recruitment mainly used student health. Four participants lacked assessable recurrence outcomes. Culture-confirmed recurrence over ten weeks affected 7/48 versus 13/48: risk ratio 0.5, 95% confidence interval 0.2–1.2. The interval includes no benefit; prevention was not established.12

Interpretation

Colonization subgroups were not randomized. Adverse events: 56% versus 50%, including discharge, itching and abdominal discomfort; brief follow-up limits safety conclusions. There was no antibiotic comparator. NIH NIDDK/ORWH funded the study; authors declared no conflicts. Osel3 was a registry collaborator.12

Availability

Osel3 describes Lactin-V as investigational, not FDA approved or available for sale. A shop-bought probiotic with different strains or administration cannot be assumed to reproduce this product’s results. These findings do not provide instructions for treating an active infection.3

NICE4 calls evidence for probiotics preventing recurrent UTIs inconclusive. Its guidance places assessment and treatment of a current UTI before considering prevention. Discuss recurrence, previous urine cultures and prior antibiotic use with the clinician reviewing your options.4

Getting assessed

The NHS5 advises seeing a GP after two UTIs within six months or three within a year. Seek urgent help for UTI symptoms with fever or shivering, pain in the back beneath the ribs, blood in urine, or pregnancy. Confusion, drowsiness or difficulty speaking requires emergency help.5

Laugh, Sneeze, Jump includes “The Red-Flag List.” Its advice to seek assessment for persistent bladder pain, visible blood or difficulty emptying is relevant when symptoms keep returning. Record what happened, when treatment ended and whether symptoms cleared before the next episode; bring those notes to the appointment.

Discuss recurrent infections with your clinician.

Read our health disclaimer

Girl Playbook sells this book. It provides education and worksheets, not individualized medical care.

Sources

The research behind this article, in the order it’s cited. How we source our articles.

  1. Clinical Infectious Diseases, 2011Lactin-V trial (opens in a new tab)ab
  2. ClinicalTrials.govNCT00305227 (opens in a new tab)ab
  3. OselFAQ (opens in a new tab)abc
  4. NICE, 2024Recurrent UTI (opens in a new tab)ab
  5. NHS, 2025UTIs (opens in a new tab)ab

Spotted something out of date? Tell us and we’ll check it.

Private questions deserve good answers.

Ten Playbooks, one for each of the problems women rarely talk about.

Shop the Playbooks